This report aims to provide a comprehensive presentation of the global market for Drug Eluting Peripheral Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Peripheral Stents. This report contains market size and forecasts of Drug Eluting Peripheral Stents in global, including the following market information:
Global Drug Eluting Peripheral Stents Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Drug Eluting Peripheral Stents Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Drug Eluting Peripheral Stents companies in 2022 (%)
The global Drug Eluting Peripheral Stents market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Carotid Artery Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Drug Eluting Peripheral Stents include Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU., Meril Life Sciences Pvt. Ltd. and Stentys SA, Cook Medical Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drug Eluting Peripheral Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Eluting Peripheral Stents Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Drug Eluting Peripheral Stents Market Segment Percentages, by Type, 2022 (%)
Carotid Artery
Iliac Artery
Infrapop Artery
Renal Artery
Carotid Artery
Global Drug Eluting Peripheral Stents Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Drug Eluting Peripheral Stents Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers/Outpatients
Global Drug Eluting Peripheral Stents Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Drug Eluting Peripheral Stents Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Eluting Peripheral Stents revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drug Eluting Peripheral Stents revenues share in global market, 2022 (%)
Key companies Drug Eluting Peripheral Stents sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Drug Eluting Peripheral Stents sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific Corporation
W. L. Gore & Associates
Abbott Laboratories
iVascular SLU.
Meril Life Sciences Pvt. Ltd.
Stentys SA, Cook Medical Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Eluting Peripheral Stents, market overview.
Chapter 2: Global Drug Eluting Peripheral Stents market size in revenue and volume.
Chapter 3: Detailed analysis of Drug Eluting Peripheral Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Eluting Peripheral Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drug Eluting Peripheral Stents capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drug Eluting Peripheral Stents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Eluting Peripheral Stents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Eluting Peripheral Stents Overall Market Size
2.1 Global Drug Eluting Peripheral Stents Market Size: 2022 VS 2030
2.2 Global Drug Eluting Peripheral Stents Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Drug Eluting Peripheral Stents Sales: 2018-2030
3 Company Landscape
3.1 Top Drug Eluting Peripheral Stents Players in Global Market
3.2 Top Global Drug Eluting Peripheral Stents Companies Ranked by Revenue
3.3 Global Drug Eluting Peripheral Stents Revenue by Companies
3.4 Global Drug Eluting Peripheral Stents Sales by Companies
3.5 Global Drug Eluting Peripheral Stents Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drug Eluting Peripheral Stents Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drug Eluting Peripheral Stents Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drug Eluting Peripheral Stents Players in Global Market
3.8.1 List of Global Tier 1 Drug Eluting Peripheral Stents Companies
3.8.2 List of Global Tier 2 and Tier 3 Drug Eluting Peripheral Stents Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Drug Eluting Peripheral Stents Market Size Markets, 2022 & 2030
4.1.2 Carotid Artery
4.1.3 Iliac Artery
4.1.4 Infrapop Artery
4.1.5 Renal Artery
4.1.6 Carotid Artery
4.2 By Type - Global Drug Eluting Peripheral Stents Revenue & Forecasts
4.2.1 By Type - Global Drug Eluting Peripheral Stents Revenue, 2018-2023
4.2.2 By Type - Global Drug Eluting Peripheral Stents Revenue, 2024-2030
4.2.3 By Type - Global Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
4.3 By Type - Global Drug Eluting Peripheral Stents Sales & Forecasts
4.3.1 By Type - Global Drug Eluting Peripheral Stents Sales, 2018-2023
4.3.2 By Type - Global Drug Eluting Peripheral Stents Sales, 2024-2030
4.3.3 By Type - Global Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
4.4 By Type - Global Drug Eluting Peripheral Stents Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drug Eluting Peripheral Stents Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Ambulatory Surgical Centers/Outpatients
5.2 By Application - Global Drug Eluting Peripheral Stents Revenue & Forecasts
5.2.1 By Application - Global Drug Eluting Peripheral Stents Revenue, 2018-2023
5.2.2 By Application - Global Drug Eluting Peripheral Stents Revenue, 2024-2030
5.2.3 By Application - Global Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
5.3 By Application - Global Drug Eluting Peripheral Stents Sales & Forecasts
5.3.1 By Application - Global Drug Eluting Peripheral Stents Sales, 2018-2023
5.3.2 By Application - Global Drug Eluting Peripheral Stents Sales, 2024-2030
5.3.3 By Application - Global Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
5.4 By Application - Global Drug Eluting Peripheral Stents Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Drug Eluting Peripheral Stents Market Size, 2022 & 2030
6.2 By Region - Global Drug Eluting Peripheral Stents Revenue & Forecasts
6.2.1 By Region - Global Drug Eluting Peripheral Stents Revenue, 2018-2023
6.2.2 By Region - Global Drug Eluting Peripheral Stents Revenue, 2024-2030
6.2.3 By Region - Global Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
6.3 By Region - Global Drug Eluting Peripheral Stents Sales & Forecasts
6.3.1 By Region - Global Drug Eluting Peripheral Stents Sales, 2018-2023
6.3.2 By Region - Global Drug Eluting Peripheral Stents Sales, 2024-2030
6.3.3 By Region - Global Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Drug Eluting Peripheral Stents Revenue, 2018-2030
6.4.2 By Country - North America Drug Eluting Peripheral Stents Sales, 2018-2030
6.4.3 US Drug Eluting Peripheral Stents Market Size, 2018-2030
6.4.4 Canada Drug Eluting Peripheral Stents Market Size, 2018-2030
6.4.5 Mexico Drug Eluting Peripheral Stents Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Drug Eluting Peripheral Stents Revenue, 2018-2030
6.5.2 By Country - Europe Drug Eluting Peripheral Stents Sales, 2018-2030
6.5.3 Germany Drug Eluting Peripheral Stents Market Size, 2018-2030
6.5.4 France Drug Eluting Peripheral Stents Market Size, 2018-2030
6.5.5 U.K. Drug Eluting Peripheral Stents Market Size, 2018-2030
6.5.6 Italy Drug Eluting Peripheral Stents Market Size, 2018-2030
6.5.7 Russia Drug Eluting Peripheral Stents Market Size, 2018-2030
6.5.8 Nordic Countries Drug Eluting Peripheral Stents Market Size, 2018-2030
6.5.9 Benelux Drug Eluting Peripheral Stents Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Drug Eluting Peripheral Stents Revenue, 2018-2030
6.6.2 By Region - Asia Drug Eluting Peripheral Stents Sales, 2018-2030
6.6.3 China Drug Eluting Peripheral Stents Market Size, 2018-2030
6.6.4 Japan Drug Eluting Peripheral Stents Market Size, 2018-2030
6.6.5 South Korea Drug Eluting Peripheral Stents Market Size, 2018-2030
6.6.6 Southeast Asia Drug Eluting Peripheral Stents Market Size, 2018-2030
6.6.7 India Drug Eluting Peripheral Stents Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Drug Eluting Peripheral Stents Revenue, 2018-2030
6.7.2 By Country - South America Drug Eluting Peripheral Stents Sales, 2018-2030
6.7.3 Brazil Drug Eluting Peripheral Stents Market Size, 2018-2030
6.7.4 Argentina Drug Eluting Peripheral Stents Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Drug Eluting Peripheral Stents Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Drug Eluting Peripheral Stents Sales, 2018-2030
6.8.3 Turkey Drug Eluting Peripheral Stents Market Size, 2018-2030
6.8.4 Israel Drug Eluting Peripheral Stents Market Size, 2018-2030
6.8.5 Saudi Arabia Drug Eluting Peripheral Stents Market Size, 2018-2030
6.8.6 UAE Drug Eluting Peripheral Stents Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Boston Scientific Corporation
7.1.1 Boston Scientific Corporation Company Summary
7.1.2 Boston Scientific Corporation Business Overview
7.1.3 Boston Scientific Corporation Drug Eluting Peripheral Stents Major Product Offerings
7.1.4 Boston Scientific Corporation Drug Eluting Peripheral Stents Sales and Revenue in Global (2018-2023)
7.1.5 Boston Scientific Corporation Key News & Latest Developments
7.2 W. L. Gore & Associates
7.2.1 W. L. Gore & Associates Company Summary
7.2.2 W. L. Gore & Associates Business Overview
7.2.3 W. L. Gore & Associates Drug Eluting Peripheral Stents Major Product Offerings
7.2.4 W. L. Gore & Associates Drug Eluting Peripheral Stents Sales and Revenue in Global (2018-2023)
7.2.5 W. L. Gore & Associates Key News & Latest Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Drug Eluting Peripheral Stents Major Product Offerings
7.3.4 Abbott Laboratories Drug Eluting Peripheral Stents Sales and Revenue in Global (2018-2023)
7.3.5 Abbott Laboratories Key News & Latest Developments
7.4 iVascular SLU.
7.4.1 iVascular SLU. Company Summary
7.4.2 iVascular SLU. Business Overview
7.4.3 iVascular SLU. Drug Eluting Peripheral Stents Major Product Offerings
7.4.4 iVascular SLU. Drug Eluting Peripheral Stents Sales and Revenue in Global (2018-2023)
7.4.5 iVascular SLU. Key News & Latest Developments
7.5 Meril Life Sciences Pvt. Ltd.
7.5.1 Meril Life Sciences Pvt. Ltd. Company Summary
7.5.2 Meril Life Sciences Pvt. Ltd. Business Overview
7.5.3 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Major Product Offerings
7.5.4 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales and Revenue in Global (2018-2023)
7.5.5 Meril Life Sciences Pvt. Ltd. Key News & Latest Developments
7.6 Stentys SA, Cook Medical Inc.
7.6.1 Stentys SA, Cook Medical Inc. Company Summary
7.6.2 Stentys SA, Cook Medical Inc. Business Overview
7.6.3 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Major Product Offerings
7.6.4 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales and Revenue in Global (2018-2023)
7.6.5 Stentys SA, Cook Medical Inc. Key News & Latest Developments
8 Global Drug Eluting Peripheral Stents Production Capacity, Analysis
8.1 Global Drug Eluting Peripheral Stents Production Capacity, 2018-2030
8.2 Drug Eluting Peripheral Stents Production Capacity of Key Manufacturers in Global Market
8.3 Global Drug Eluting Peripheral Stents Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drug Eluting Peripheral Stents Supply Chain Analysis
10.1 Drug Eluting Peripheral Stents Industry Value Chain
10.2 Drug Eluting Peripheral Stents Upstream Market
10.3 Drug Eluting Peripheral Stents Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drug Eluting Peripheral Stents Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Drug Eluting Peripheral Stents in Global Market
Table 2. Top Drug Eluting Peripheral Stents Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Drug Eluting Peripheral Stents Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Drug Eluting Peripheral Stents Revenue Share by Companies, 2018-2023
Table 5. Global Drug Eluting Peripheral Stents Sales by Companies, (K Units), 2018-2023
Table 6. Global Drug Eluting Peripheral Stents Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Drug Eluting Peripheral Stents Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Drug Eluting Peripheral Stents Product Type
Table 9. List of Global Tier 1 Drug Eluting Peripheral Stents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Eluting Peripheral Stents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Drug Eluting Peripheral Stents Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Drug Eluting Peripheral Stents Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Drug Eluting Peripheral Stents Sales (K Units), 2018-2023
Table 15. By Type - Global Drug Eluting Peripheral Stents Sales (K Units), 2024-2030
Table 16. By Application ? Global Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Drug Eluting Peripheral Stents Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Drug Eluting Peripheral Stents Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Drug Eluting Peripheral Stents Sales (K Units), 2018-2023
Table 20. By Application - Global Drug Eluting Peripheral Stents Sales (K Units), 2024-2030
Table 21. By Region ? Global Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Drug Eluting Peripheral Stents Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Drug Eluting Peripheral Stents Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Drug Eluting Peripheral Stents Sales (K Units), 2018-2023
Table 25. By Region - Global Drug Eluting Peripheral Stents Sales (K Units), 2024-2030
Table 26. By Country - North America Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Drug Eluting Peripheral Stents Sales, (K Units), 2018-2023
Table 29. By Country - North America Drug Eluting Peripheral Stents Sales, (K Units), 2024-2030
Table 30. By Country - Europe Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Drug Eluting Peripheral Stents Sales, (K Units), 2018-2023
Table 33. By Country - Europe Drug Eluting Peripheral Stents Sales, (K Units), 2024-2030
Table 34. By Region - Asia Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Drug Eluting Peripheral Stents Sales, (K Units), 2018-2023
Table 37. By Region - Asia Drug Eluting Peripheral Stents Sales, (K Units), 2024-2030
Table 38. By Country - South America Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Drug Eluting Peripheral Stents Sales, (K Units), 2018-2023
Table 41. By Country - South America Drug Eluting Peripheral Stents Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Drug Eluting Peripheral Stents Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Drug Eluting Peripheral Stents Sales, (K Units), 2024-2030
Table 46. Boston Scientific Corporation Company Summary
Table 47. Boston Scientific Corporation Drug Eluting Peripheral Stents Product Offerings
Table 48. Boston Scientific Corporation Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Boston Scientific Corporation Key News & Latest Developments
Table 50. W. L. Gore & Associates Company Summary
Table 51. W. L. Gore & Associates Drug Eluting Peripheral Stents Product Offerings
Table 52. W. L. Gore & Associates Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. W. L. Gore & Associates Key News & Latest Developments
Table 54. Abbott Laboratories Company Summary
Table 55. Abbott Laboratories Drug Eluting Peripheral Stents Product Offerings
Table 56. Abbott Laboratories Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Abbott Laboratories Key News & Latest Developments
Table 58. iVascular SLU. Company Summary
Table 59. iVascular SLU. Drug Eluting Peripheral Stents Product Offerings
Table 60. iVascular SLU. Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. iVascular SLU. Key News & Latest Developments
Table 62. Meril Life Sciences Pvt. Ltd. Company Summary
Table 63. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product Offerings
Table 64. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Meril Life Sciences Pvt. Ltd. Key News & Latest Developments
Table 66. Stentys SA, Cook Medical Inc. Company Summary
Table 67. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product Offerings
Table 68. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Stentys SA, Cook Medical Inc. Key News & Latest Developments
Table 70. Drug Eluting Peripheral Stents Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global Drug Eluting Peripheral Stents Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Drug Eluting Peripheral Stents Production by Region, 2018-2023 (K Units)
Table 73. Global Drug Eluting Peripheral Stents Production by Region, 2024-2030 (K Units)
Table 74. Drug Eluting Peripheral Stents Market Opportunities & Trends in Global Market
Table 75. Drug Eluting Peripheral Stents Market Drivers in Global Market
Table 76. Drug Eluting Peripheral Stents Market Restraints in Global Market
Table 77. Drug Eluting Peripheral Stents Raw Materials
Table 78. Drug Eluting Peripheral Stents Raw Materials Suppliers in Global Market
Table 79. Typical Drug Eluting Peripheral Stents Downstream
Table 80. Drug Eluting Peripheral Stents Downstream Clients in Global Market
Table 81. Drug Eluting Peripheral Stents Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drug Eluting Peripheral Stents Segment by Type in 2022
Figure 2. Drug Eluting Peripheral Stents Segment by Application in 2022
Figure 3. Global Drug Eluting Peripheral Stents Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drug Eluting Peripheral Stents Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Drug Eluting Peripheral Stents Revenue, 2018-2030 (US$, Mn)
Figure 7. Drug Eluting Peripheral Stents Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Drug Eluting Peripheral Stents Revenue in 2022
Figure 9. By Type - Global Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
Figure 11. By Type - Global Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
Figure 12. By Type - Global Drug Eluting Peripheral Stents Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
Figure 15. By Application - Global Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
Figure 16. By Application - Global Drug Eluting Peripheral Stents Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Drug Eluting Peripheral Stents Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
Figure 20. By Region - Global Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
Figure 21. By Country - North America Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
Figure 22. By Country - North America Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
Figure 23. US Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
Figure 28. Germany Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 29. France Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
Figure 37. China Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 41. India Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
Figure 43. By Country - South America Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
Figure 44. Brazil Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Drug Eluting Peripheral Stents Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share, 2018-2030
Figure 48. Turkey Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Drug Eluting Peripheral Stents Revenue, (US$, Mn), 2018-2030
Figure 52. Global Drug Eluting Peripheral Stents Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Drug Eluting Peripheral Stents by Region, 2022 VS 2030
Figure 54. Drug Eluting Peripheral Stents Industry Value Chain
Figure 55. Marketing Channels
